Archives
-
Sunitinib B1045: Reliable Cell Assay Workflows
2026-08-30
This scenario-based guide shows how Sunitinib (SKU B1045) can improve the design, interpretation, and reproducibility of cell viability, proliferation, and cytotoxicity assays. It links formulation details and recent renal cell carcinoma evidence to practical decisions about controls, dose ranges, readouts, and supplier reliability.
-
Q-VD-OPh: A Mechanistic Guide to Cell Death
2026-08-29
Q-VD-OPh is a cell-permeable pan-caspase inhibitor for dissecting apoptosis from lysosome-dependent cell death. This guide explains how to use its caspase activity inhibition profile as a mechanistic control in apoptosis research, neurodegeneration studies, and post-cryopreservation workflows.
-
Z-IETD-FMK in Morphotype-Aware Apoptosis Studies
2026-08-28
Z-IETD-FMK enables pathway-level interrogation of caspase-8-dependent apoptosis. This article translates Candida krusei morphotype findings into a practical, control-driven framework for distinguishing death-receptor signaling from mitochondrial apoptosis.
-
Q-VD(OMe)-OPh for Reliable Apoptosis Assays
2026-08-27
Learn how Q-VD(OMe)-OPh (SKU A8165) can help laboratories distinguish caspase-dependent apoptosis from ferroptosis, autophagy, and other causes of reduced viability. This scenario-based guide covers assay design, solvent handling, data interpretation, and practical supplier-selection criteria.
-
Macrophage Depletion as a Causal Test in Liver I/R
2026-08-26
A translational framework for using Clodronate Liposomes to test whether macrophage populations are necessary for paeoniflorin-mediated protection in hepatic ischemia-reperfusion injury, while preserving mechanistic rigor, experimental controls, and realistic expectations for clinical translation.
-
L-NAME Hydrochloride for Reliable Cell Assays
2026-08-25
Learn how L-NAME Hydrochloride (SKU A7088) can help researchers separate nitric oxide biology from assay noise in viability, proliferation, cytotoxicity, and vascular studies. This scenario-based guide covers concentration selection, solvent compatibility, controls, interpretation, and practical product evaluation.
-
PF-573228: FAK Inhibitor Workflow Guide
2026-08-24
PF-573228 provides a tunable way to test how focal adhesion kinase converts matrix mechanics into cell fate, migration, and survival signals. This practical guide connects stiffness-controlled dentinogenesis assays with endothelial and cancer models while emphasizing dose control, phospho-FAK validation, and troubleshooting.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-23
This 2026 FASEB Journal study developed chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The formulation restored nuclear p21, altered cell-cycle and DNA-damage markers, suppressed orthotopic tumor growth, and produced strong bladder-localized expression with limited systemic distribution in mice.
-
Macrophage TIPE2 Drives ASC Ferroptosis in Obesity
2026-08-22
This Nature Communications study identifies a macrophage–adipose stem cell circuit that links obesity-associated inflammation to ferroptotic loss of adipose stem cells and visceral fat dysfunction. Its central mechanistic insight is that macrophage TIPE2 preserves exosomal ferritin delivery by restraining the IP3R–Ca2+–Drp1 mitochondrial fission axis, suggesting a cellular route for restoring adipose tissue homeostasis.
-
Mitoxantrone HCl: Practical DNA Damage Workflows
2026-08-21
Mitoxantrone HCl supports more than conventional cytotoxicity studies: it enables controlled investigation of topoisomerase II-mediated DNA damage, apoptosis, immune-cell modulation, and ERα degradation. This bench-focused guide covers formulation, dose-response design, orthogonal readouts, and troubleshooting for cancer and stem-cell models.
-
Tirbanibulin in HPV-Positive HeLa Cells
2026-08-16
This 2024 study shows that tirbanibulin suppresses proliferation of HPV-18-containing HeLa cells while reducing protein expression across Src–MEK-associated, cell-cycle, invasion, and survival pathways. Its integrated immunoblotting approach provides a mechanistic framework for understanding how an approved actinic keratosis treatment may also affect HPV-associated oncogenic signaling, while leaving direct antiviral and clinical efficacy questions unresolved.
-
ATM Inhibition and Fenofibrate in HGSOC
2026-08-15
The reference study identifies a metabolic vulnerability associated with ATM activity in high-grade serous ovarian cancer (HGSOC). It shows that pharmacologic ATM inhibition can synergize with fenofibrate, a PPARα agonist, to induce senescence in HGSOC cells, offering a combination strategy that extends beyond conventional DNA damage-based treatment.
-
AZD0156: Reliable ATM Inhibition in Viability Assays
2026-08-14
Learn how AZD0156 (SKU B7822) can support better-controlled cell viability, proliferation, and cytotoxicity studies by combining selective ATM pathway inhibition with practical formulation guidance. This scenario-driven guide addresses metabolic assay confounding, solvent compatibility, protocol design, interpretation, and product-selection criteria.
-
Q-VD(OMe)-OPh: Pan-Caspase Inhibition Guide
2026-08-13
Q-VD(OMe)-OPh is a broad-spectrum pan-caspase inhibitor for controlled apoptosis experiments. Its recombinant-caspase activity profile and low reported cytotoxicity make it useful for apoptosis assay design, pathway dissection, and interpretation of complex cell-death models.
-
Cardamomin Protects Against Oxidative Ischemic Injury
2026-08-12
The reference study links cardamomin from Amomum villosum stems and leaves to protection against hydrogen peroxide-induced oxidative damage and permanent cerebral ischemia. Its central contribution is a multi-level mechanism involving MEK/ERK-driven NRF2 activation, suppression of oxeiptosis and parthanatos, and improved tissue viability in a rat stroke model.